Literature DB >> 12726851

Determination of zaleplon and zolpidem by liquid chromatography-turbo-ionspray mass spectrometry: application to forensic cases.

Christian Giroud1, Marc Augsburger, Annick Menetrey, Patrice Mangin.   

Abstract

Zolpidem and zaleplon are two short-acting hypnotic agents used in Europe and in the USA. An atmospheric pressure ionisation liquid chromatography-mass spectrometry (Sciex API 150 EX) method was developed for the determination of zolpidem and zaleplon in whole blood. After single-step liquid-liquid extraction, the hypnotics were separated by gradient-elution with an ammonium formate buffer/acetonitrile eluent on an Inertsil ODS-3 column. Methaqualone was used as internal standard. The recovery was higher than 70% for both hypnotics and the internal standard. The best fit for the calibration curve was achieved, between 1 and 250 ng/ml, with 1/x quadratic regression. Coefficients of intra- and inter-assay variation calculated at 5, 25 and 100 ng/ml were less than 10%. The method was successfully applied to forensic cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726851     DOI: 10.1016/s1570-0232(03)00135-1

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Zolpidem : Forensic aspects for the toxicologist and pathologist.

Authors:  Timothy P Rohrig; Christine M Moore
Journal:  Forensic Sci Med Pathol       Date:  2005-06       Impact factor: 2.456

2.  Development and Validation of a Stability-Indicating Capillary Electrophoresis Method for the Determination of Zolpidem Tartrate in Tablet Dosage Form with Positive Confirmation using 2D- and 3D-DAD Fingerprints.

Authors:  Khaldun M Al Azzam; Lee Kam Yit; Bahruddin Saad; Hassan Shaibah
Journal:  Sci Pharm       Date:  2014-02-27

3.  Quantitation of zolpidem in biological fluids by electro-driven microextraction combined with HPLC-UV analysis.

Authors:  Saeid Yaripour; Ali Mohammadi; Isa Esfanjani; Roderick B Walker; Saeed Nojavan
Journal:  EXCLI J       Date:  2018-04-23       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.